CBLL Stock Analysis: Buy, Sell, or Hold?
CBLL - CeriBell, Inc. Common Stock
$16.30
-0.16 (-0.97%)
▼
5d:
-19.31%
30d:
-21.41%
90d:
-17.55%
WAIT
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Get Alerted When CBLL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CBLL is down 19.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CBLL is down 19.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CBLL is currently trading at $16.30, which is considered oversold relative to its 30-day fair value range of $18.32 to $21.25.
Technical Outlook: Technically, CBLL is in a downtrend. The price is currently testing key support at $15.84. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $26.86 (+64.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CBLL is in a downtrend. The price is currently testing key support at $15.84. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $26.86 (+64.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$18.32 -
$21.25
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 64.8% below Wall St target ($26.86)
- WARNING: Recommendation downgraded due to -19.3% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$18.32 -
$21.25
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$15.84
Resistance Level
$20.93
Current Trend
Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-14.79
Wall Street Target
$26.86
(+64.8%)
Revenue Growth (YoY)
29.3%
Profit Margin
-63.5%
Share & Embed Analysis
Last updated: May 18, 2026 5:03 AM ET
Data refreshes hourly during market hours. Next update: 6:03 AM
Data refreshes hourly during market hours. Next update: 6:03 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CBLL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Xingjuan Chao
SELL
39000 shares
2026-04-06
Raymond Woo
SELL
11112 shares
2026-04-01
Rebecca B Robertson
SELL
827 shares
2026-03-03
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$389 | 58 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 64 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 55 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$250 | 59 HOLD |
